OCTN2-Mediated Acetyl-l-Carnitine Transport in Human Pulmonary Epithelial Cells In Vitro

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Pharmacology

Background:

• The carnitine transporter OCTN2 is implicated in inflammatory diseases like asthma.
• Understanding carnitine transport is crucial for respiratory health research.

Purpose of the Study:

• To quantify carnitine uptake in primary human alveolar type I (ATI)-like cells.
• To compare carnitine uptake kinetics across different respiratory epithelial cell models.
• To evaluate the suitability of cell lines as models for air-blood barrier carnitine transport.

Main Methods:

• Primary human ATI-like epithelial cells were cultured.
• Acetyl-l-carnitine uptake was measured in primary cells and cell lines (NCl-H441, Calu-3, A549).
• The effect of OCTN2 modulators (l-Carnitine, verapamil) on uptake was assessed.

Main Results:

• Acetyl-l-carnitine uptake was similar in ATI-like, NCl-H441, and Calu-3 cells, but 5x higher in A549 cells.
• OCTN2 modulator-induced uptake inhibition was more significant in primary ATI-like cells than in NCl-H441 and Calu-3 cells.
• Primary cells showed distinct carnitine transport characteristics compared to tested cell lines.

Conclusions:

• OCTN2 plays a role in acetyl-l-carnitine uptake in the alveolar epithelium.
• Currently available respiratory epithelial cell lines are not ideal models for studying carnitine transport at the air-blood barrier.
• Primary alveolar epithelial cells are superior models for carnitine transport research relevant to the air-blood barrier.